About pcm
Manuscript Submission
AME Editing Service
Reprint & Permission
Advertising
Contact us
-
General editorial enquiries:
Email: pcm@amegroups.com -
Copyright related contact:
Email: permissions@amegroups.com -
Commercial Sales contact (Reprints, advertising, etc.):
Email: sales@amegroups.com
Case Report
Precision Cancer Medicine
2022;
5:
10
(30 March 2022)
Case Report
Precision Cancer Medicine
2022;
5:
9
(30 March 2022)
Case Report
Precision Cancer Medicine
2022;
5:
8
(30 March 2022)
Case Report
Precision Cancer Medicine
2022;
5:
7
(30 March 2022)
Review Article
Precision Cancer Medicine
2022;
5:
6
(30 March 2022)
Review Article
Precision Cancer Medicine
2022;
5:
5
(30 March 2022)
Review Article
Precision Cancer Medicine
2022;
5:
4
(30 March 2022)
Review Article
Precision Cancer Medicine
2022;
5:
3
(30 March 2022)
Original Article
Precision Cancer Medicine
2022;
5:
2
(30 March 2022)
Editorial
Precision Cancer Medicine
2022;
5:
1
(30 March 2022)
Editorial Commentary
Precision Cancer Medicine
2021;
4:
40
(30 December 2021)
Case Report
Precision Cancer Medicine
2021;
4:
39
(30 December 2021)
Review Article
Precision Cancer Medicine
2021;
4:
38
(30 December 2021)
Review Article
Precision Cancer Medicine
2021;
4:
37
(30 December 2021)
Review Article
Precision Cancer Medicine
2021;
4:
36
(30 December 2021)
Review Article
Precision Cancer Medicine
2021;
4:
35
(30 December 2021)
Review Article
Precision Cancer Medicine
2021;
4:
34
(30 December 2021)
Review Article
Precision Cancer Medicine
2021;
4:
33
(30 December 2021)
Review Article
Precision Cancer Medicine
2021;
4:
32
(30 December 2021)
Original Article
Precision Cancer Medicine
2021;
4:
31
(30 December 2021)